307 related articles for article (PubMed ID: 24862146)
1. Bleeding complications during anticoagulant treatment in patients with cancer.
Kamphuisen PW; Beyer-Westendorf J
Thromb Res; 2014 May; 133 Suppl 2():S49-55. PubMed ID: 24862146
[TBL] [Abstract][Full Text] [Related]
2. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
4. Bleeding complications associated with anticoagulant therapy in patients with cancer.
Trujillo-Santos J; Nieto JA; Ruíz-Gamietea A; López-Jiménez L; García-Bragado F; Quintavalla R; Monreal M;
Thromb Res; 2010 Apr; 125 Suppl 2():S58-61. PubMed ID: 20434007
[TBL] [Abstract][Full Text] [Related]
5. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.
Davidson BL; Verheijen S; Lensing AW; Gebel M; Brighton TA; Lyons RM; Rehm J; Prins MH
JAMA Intern Med; 2014 Jun; 174(6):947-53. PubMed ID: 24733305
[TBL] [Abstract][Full Text] [Related]
6. Safety of anticoagulant treatment in cancer patients.
Wilts IT; Bleker SM; Van Es N; Büller HR; Di Nisio M; Kamphuisen PW
Expert Opin Drug Saf; 2015 Aug; 14(8):1227-36. PubMed ID: 26059964
[TBL] [Abstract][Full Text] [Related]
7. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.
Riva N; Bellesini M; Di Minno MN; Mumoli N; Pomero F; Franchini M; Fantoni C; Lupoli R; Brondi B; Borretta V; Bonfanti C; Ageno W; Dentali F
Thromb Haemost; 2014 Sep; 112(3):511-21. PubMed ID: 24899092
[TBL] [Abstract][Full Text] [Related]
8. [Optimal duration of anticoagulation of venous thromboembolism].
Savina EN; Couturaud F
J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
[TBL] [Abstract][Full Text] [Related]
9. Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):139-44. PubMed ID: 21822525
[TBL] [Abstract][Full Text] [Related]
10. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.
Kopolovic I; Lee AY; Wu C
Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031
[TBL] [Abstract][Full Text] [Related]
11. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
Kuperman A; López-Reyes R; Bosco LJ; Lorenzo A; José B; Farge Bancel D; Alfonso M; Lumbierres M; Stemer G; Monreal Bosch M; Braester A;
J Thromb Thrombolysis; 2018 Apr; 45(3):360-368. PubMed ID: 29383557
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
[TBL] [Abstract][Full Text] [Related]
13. Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review.
Klok FA; Kooiman J; Huisman MV; Konstantinides S; Lankeit M
Eur Respir J; 2015 Jan; 45(1):201-10. PubMed ID: 25102964
[TBL] [Abstract][Full Text] [Related]
14. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
15. Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
Menapace LA; McCrae KR; Khorana AA
Thromb Res; 2016 Apr; 140 Suppl 1():S93-8. PubMed ID: 27067987
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism in cancer patients.
Petralia GA; Kakkar AK
Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation for prevention and treatment of cancer-related venous thromboembolism.
Barsam SJ; Patel R; Arya R
Br J Haematol; 2013 Jun; 161(6):764-77. PubMed ID: 23560605
[TBL] [Abstract][Full Text] [Related]
18. Duration of anticoagulant therapy for patients with venous thromboembolism.
Garcia D
Thromb Res; 2008; 123 Suppl 1():S62-4. PubMed ID: 18823648
[TBL] [Abstract][Full Text] [Related]
19. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
Couturaud F; Kearon C
Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
[TBL] [Abstract][Full Text] [Related]
20. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.
Nieto JA; Solano R; Trapero Iglesias N; Ruiz-Giménez N; Fernández-Capitán C; Valero B; Tiberio G; Bura-Riviere A; Monreal M;
Thromb Res; 2013 Aug; 132(2):175-9. PubMed ID: 23849097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
